Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well-documented publication which meets basic scientific principles

Data source

Reference
Reference Type:
publication
Title:
Distribution and Excretion of Monoisopropylnaphthalene in Rats
Author:
Kojima S, Babasaki T, Kiyozumi M, Nakagawa M
Year:
1981
Bibliographic source:
Bull. Environ. Contam. Toxicol., 26, 626-633

Materials and methods

Objective of study:
distribution
excretion
metabolism
Principles of method if other than guideline:
Toxicokinetics study
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Isopropylnaphthalene
EC Number:
249-535-3
EC Name:
Isopropylnaphthalene
Cas Number:
29253-36-9
Molecular formula:
C13H14
IUPAC Name:
1-(propan-2-yl)naphthalene; 2-(propan-2-yl)naphthalene
Details on test material:
- Name of test material (as cited in study report): Monoisopropylnaphthalene (MIPN), isomer mixture [CAS no. 29253-36-9]
- Name of second comparative test material (as cited in study report): and 1-isopropylnaphthalene (1-IPN) [CAS no. 6158-45-8 / EC no. 228-177-1]
- Substance type: organic
- Isomers composition of MIPN isomer mixture: 60% 2-isoppropylnaphthalene, 40% 1-isopropylnaphthalene
plus 60% 2-isopropyl [14C]naphthalene, 40% 1-isopropyl[14C]naphthalene
- Specific activity (if radiolabelling): 5.65 µCi/mg
- Locations of the label (if radiolabelling): naphthalene ring

Test substances are obtained from Kureha Chemical Co., Tokyo

Radiolabelling:
yes

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS (Oral administration experiment)
- Weight at study initiation: 190 - 210 g
- Housing: Individual metabolism cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum

TEST ANIMALS (In situ biliary excretion experiment)
- The bile duct of animals anesthetised with ethyl ether was cannulated with PE-10 tubing in order to collect bile fluid.
- Weight at study initiation: 170 - 220 g
- Housing: Individual in Bollman cages (after oral administration of MIPN-14C in olive oil)
- Diet: ad libitum
- Water: ad libitum

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Duration and frequency of treatment / exposure:
single dose
Doses / concentrations
Remarks:
Doses / Concentrations:
Group 1: Single dose of MIPN-14C (6.25 µCi/kg bw) plus non-labelled MIPN (100mg/kg bw)
Group 2: Single dose of non-labelled 1-IPN (100mg/kg bw)
No. of animals per sex per dose / concentration:
3 at each sampling time
Control animals:
no
Details on dosing and sampling:
PHARMACOKINETIC STUDY (Distribution, excretion)
- Body fluids sampled: urine, faeces, bile, blood
- Examined tissues: Adipose, skin, liver, kidneys, brain, muscle, , spleen
- Time and frequency of sampling: Feces and urine were collected separately 24, 48, 72, and 96 hr after administration
- Animals treated with 14C-MIPN were sacrificed at 2, 4, 6, 12 and 24 hr after administration, and tissues were collected for analysis.
- Animals treated with 1-IPN were sacrificed at 2, 6, 12 and 24 hr after administration. and tissues were collected for analysis.
- Time and frequency of sampling of bile in the biliary excretion experiment: 2, 4, 6, 8, 24, and 48 hr after administration.

PREPARATION OF TISSUES AND ANALYSIS OF RADIOACTIVITY:
- Decoloration of 100 mg tissue by warming at 45°C (3-5 hr) with 0.3 ml H2O2 (30%)
- Dissolving by adding 1.2 ml NCS solubilizer and warming (45°C) for 5-6 hr.
- After neutralisation wtih 0.05 ml of glacial acetic acid 10 ml of PCS scintillation cocktail was added.
- Determination of radioactivity with a liquid scintillation counter

PREPARATION OF URINE AND BILE AND ANALYSIS OF RADIOACTIVITY:
- Differentiation of conjugated and unconjugated metabolites of MIPN-14C by extraction with chloroform after pH adjustment to 1.0 - 2.0.
- Determination of radioactivity of the chloroform and aqueous layer

PREPARATION OF FECES AND ANALYSIS OF RADIOACTIVITY:
- Aliquots of 100 mg of the dried and powdered faeces were oxidised (Tri-carb sample oxidizer) and 14-CO2 was trapped into Carbo-sorb carbon dioxide absorber.
- Permafluor V scintillation cocktail was added and counted in a liquid scintillation counter.

Recoveries of radioactivity was 80-85% with these procedures.


Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on distribution in tissues:
Maximal levels of radioactivity in all tissues were reached after 4 h, except skin (6 h) and spleen (6 h). In blood the level kept nearly constant until 12 h after administration. Then levels decreased with time. The highest maximum level of radioactivity were found in adipose tissue followed in descending order by skin > liver, kidney >brain > spleen > muscle.

Maximal levels of 1-IPN in liver, kidney and adipose were reached after 2 - 6 h after administration (relative constant values in this interval). Then 1-IPN levels decreased with time. Maximum level in skin was reached after 6 h hours and then level decreased rapidly. Maximum 1-IPN concentration in brain, muscle and spleen as well in blood was measured after 2 h. Afterwards the levels decreased more or less rapidly.
The highest maximum 1-IPN concentration was found in adipose tissue followed in descending order by skin > liver, brain > kidney > spleen, muscle, blood.
Details on excretion:
More than 50% of the total dose of radioactivity was excreted after 24 h via urine. After 96 h 78% of the total dose was excreted via urine.
14% of total dose was excreted via faeces after 96 h.
The excretion of radioactivity in the bile fluid was approx. 60% of the total dose. In consideration of the result that faecal excretion is the minor route of excretion of radioactivity derived from MIPN-14C, it was concluded that enterohepatic circulation is important in the reabsorption of the metabolites excreted into the intestine via the bile.

Metabolite characterisation studies

Metabolites identified:
no
Details on metabolites:
Conjugated and non-conjugated metabolites were found by TLC, but not identified.

Any other information on results incl. tables

The time courses of MIPN-14C and 1-IPN concentrations in tissues are different. Radioactivity descended less rapid than the level of 1-IPN. Especially in blood, the level of radioactivity kept nearly constant on the maximum level until 12 h, whereas the level of unchanged 1-IPM descended rapidly between 2 h and 12 h after administration. It can be concluded, that MIPN was metabolized with time, but the metabolites remained much longer in tissues and blood.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): no bioaccumulation potential based on study results